Market Size in 2021 | Market Forecast in 2028 | Growth Rate (in %) | Base Year |
---|---|---|---|
USD 782.4 million | USD 1,819.2 million | CAGR at 15.1% | 2021 |
FrequentlyAsked Questions
Rising technical development and interest in minimally invasive surgery are expected to drive the market. One of the key factors influencing the market is the rising incidence of peripheral and coronary artery disorders worldwide.
According to the report, the global drug-coated balloons market was worth 782.4 (USD million) in 2021 and is predicted to grow to 1,819.2 (USD million) by 2028, with a compound annual growth rate (CAGR) of around 15.1%.
The market for drug coating balloons is projected to be dominated by the North American area. The high prevalence of cardiovascular disease diagnosis and treatment, and rising healthcare spending are expected to bode well for the drug-coating balloon industry in North America.
Some of the main competitors dominating the global drug-coated balloons market include - Aachen Resonance, Acotec Scientific, AR Baltic Medical, Biosensors International Group, BIOTRONIK, Cardionovum, Concept Medical, Eucatech, ENDOCOR, HEXACATH, iVascular, MA Med Alliance, Meril Life Sciences, Nano Therapeutics, QT Vascular, RD Global-Invamed, STENTYS, Surmodics, Terumo, Urotronic, and Welling.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed